Although the contribution of reduction of tumor-associated macrophages to the observed results in these experimental studies has yet to be determined, pathological correlation in this aspect in the clinical trials employing anti-VEGF therapy would be of great interest. The gene discussed is VEGFA; the disease is neoplasm.